Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seeing as how many are hugely underwater and have not much choice left but to hold and hope, who's going to sell?
only 10,000 left at .0115
It was hit for 10,000 and it dropped from 20k to 10k.
For whatever reason we have very little selling pressure right now, sorta odd being there has to be 100s of investors I would guess.
Will take it.
Yes, that would be what they are working on, a partner to fund the finishing of construction.
If they can pull it off it would be grandslam without Cobroxin.
But no money to exercise that option, right?
Big condo/hotel next to DisneyWorld that is half constructed. They have an option on it.
But we have absolutely no idea what (if?) real estate XCHO actually owns, do we?
Hi STS, maybe something is up, today was quieter, but still more action than normal.
I noticed that too - biggest volume day since Dec 21, 2011 - no news that I can find?
Unusual Demand and Narrow Spread
This is totally out of the norm for XCHO today, .01B .011A And its trading at .011
Nice change
They think their FL real estate stuff will work out. FL real estate is recoverying.
I noticed the volume today too, although it is not much dollar wize.
did you find out something ?
thx in advance for sharing
100k +Up a tad today
Bout time I checked in with company to see if anything is happening
STS, thanks for your comments. XCHO did buy a lot of Cobroxin to help out NPHC they stocked up at rate faster than they were selling it, they paid like $2-3 a bottle to NPHC so their over $1 mill worth of wholesale orders if it was that would be like $7 million at retail. Just my guess they still have inventory.
In November 2009, XenaCare began selling Cobroxin to brick-and-mortar retailers, including distribution to CVS in March 2010 and Walgreens in May 2010. On April 1, 2011, we notified our Cobroxin Distributor, XenaCare Holdings that they were in breach of our agreement. As a result of this, the distribution agreement was terminated effective April 10, 2011.
That's exactly what I recall reading somewhere, the termination notice.
XenaCare continues to market their existing inventory of Cobroxin.
<cough> BS! I cannot believe XCHO had anywhere close to the resources necessary to buy such a huge amount of inventory that they're still selling it today, and my experience in attempting to buy both the spray and gel proves this out, especially for the much more popular spray - there was a time, maybe 3-4 months ago, when I could not find the spray ANYWHERE online - every website said "out of stock". Then suddenly after a month or so passed everyone was stocked up again - clearly the inventory was refreshed!
We have been in negotiations with potential new distributors for our Cobroxin products both domestically and internationally.
And how's that goin' for ya, Rik? Not well, it would appear.....
"NPHC has PRed for 1.5 years deals here and there and there and there for Nyloxin, yet never produce any sales on their Qs. have you noticed that."
Not really, since I don't own a single share of NPHC and never have, as you know.....but I'm not surprised either given the disparity in pricing! One product has 2 times as much cobratoxin in it than the other, as someone pointed out to me on the NPHC board, but the labels on both say "3X", the homeopathic symbol for product dilution,
The Y-X is an inverse symbol of strength, to anyone familiar with homeopathy, and as neither product are "true" homeopathics, why would anyone pay double the price for something that appears to be identical? Nowhere on either label is the term "cobratoxin" mentioned, nor is product strength in mcg/ml.
More info on distribution:
From last NPHC 10Q Oct 2011
NPHC is now claiming sales of Nyloxin, and Amazon does show a one seller. http://www.amazon.com/NYLOXIN-Topical-Quantity-NutraPharma-4721931002/dp/B004YTVWU0
But do not see any significant sales of Cobroxin by NPHC and they admit they have no distributor at this time, excpet they admit XCHO is distributing it:
During August 2011, we received regulatory approval to market Nyloxin in India.
Retail Sales and Distribution
During the third quarter of 2011, we generated revenues of $243,322 from Nyloxin sales. During the quarter we continued to focus on expanding brand awareness for our over-the-counter pain relievers Nyloxin and Nyloxin Extra Strength by: (a) coordinating marketing and awareness for those pain relievers through attendance at various conferences; (b) seeking out additional international distribution partners for our Nyloxin branded pain relievers; and (c) coordinating our ongoing drug registration process in Europe, Canada, Central America, South America, the Middle East, Mexico, and India, including reviewing distributor candidates within those territories. We plan to continue our brand development and operations during the remainder of 2011 by continuing the above efforts, researching potential product line extensions for our branded pain relievers and organizing clinical studies that support our current drug products and advance our current research and development pipeline.
Cobroxin
We offer Cobroxin, our over-the-counter pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain that was developed by ReceptoPharm, our drug discovery arm and wholly owned subsidiary. Cobroxin is marketed online and at retailers through our United States distributor, XenaCare. In August 2009, we completed an agreement with XenaCare granting it the exclusive license to market and distribute Cobroxin within the United States. In mid-November 2009, XenaCare began selling Cobroxin online through its product website, Cobroxin.com.
In November 2009, XenaCare began selling Cobroxin to brick-and-mortar retailers, including distribution to CVS in March 2010 and Walgreens in May 2010. On April 1, 2011, we notified our Cobroxin Distributor, XenaCare Holdings that they were in breach of our agreement. As a result of this, the distribution agreement was terminated effective April 10, 2011. XenaCare continues to market their existing inventory of Cobroxin. We have been in negotiations with potential new distributors for our Cobroxin products both domestically and internationally.
STS, Editing was too late. Here it is edited.
Hi STS, NPHC has publically stated that, but in reality XCHO is the seller of Cobroxin. If you look at the box, it says manufactured for XenaCare. The two companies are fighting but XCHO is the defacto distributor. You can call XCHO and order a bottle and ask them about it. They confirmed to me this week they are selling it now and will continue to and have no supply problems at this time, whether inventory or new supplies I did not ask.
Now they are not going to spend money on ads while the fight is still going on, part of how NPHC shot themselves in the foot by PRing they had taken the exclusive away.
NPHC has PRed for 2 years deals here and there and there and there for Nyloxin, yet never produce any sales on their Qs until very recently.
NPHC has said they took the marketing rights back on Cobroxin 1.5 years ago, yet where on there books are any retail sales of Cobroxin? Nowhere. NPHC PRs have proven to be almost all air and no substance.
Cheers
Of course Hotstock, me too. Maybe it will happen. My guess is they are conserving cash right now as things are worked out.
Hi STS, NPHC has publically stated that, but in reality XCHO is the seller of Cobroxin. If you look at the box, it says manufactured for XenaCare. The two companies are fighting but XCHO is the defacto distributor. You can call XCHO and order a bottle and ask them about it. They confirmed to me this week they are selling it now and will continue to and have no supply problems.
Now they are not going to spend money on ads while the fight is still going on, part of how NPHC shot themselves in the foot by PRing they had taken the exclusive away.
NPHC has PRed for 1.5 years deals here and there and there and there for Nyloxin, yet never produce any sales on their Qs. have you noticed that.
Cheers
I swear to god I read one of the companies 8-K's or 10-Q's that definitively stated the severing of XCHO's Cobroxin distribution contract with NPHC - in fact, I think it was you that first reported it! That was when/why XCHO started to dabble in FL real estate, IIRC - and I *do* recall BE rubbing our noses in it when the dist. rights were supposedly lost. Me confused....
would like for XCHO to come back reporting Q's en K's
go XCHO
STS, XCHO is the only company that has ever sold Cobroxin, they own the UPC code got the distribution etc.
NPHC tried to go into competition with them a few months after XCHO had success in terms of distribution and sales, with Nyloxin. But there is not a single store 18 months later that has Nyloxin. It appears to have been just talk, NPHC never produced any Nyloxin sales in their Qs.
Not that things are rosy with XCHO, this whole Nyloxin thing did hurt as it meant XCHO did not have a defacto exclusive.
Wait a sec - you talked to someone at XCHO and they said they were still selling/distributing Cobroxin?!?! I thought they lost the rights last year - WTF? I've always wondered who was putting in on the shelves since NPHC supposedly cut them off - what's the real deal? Could there actually be hope for our near valueless XCHO shares?
Amazon thing was corrected.
Right now see two Cobroxin resellers on Amazon, no special notes.
Did talk to company today (XCHO) and they said they are shipping Cobroxin now and will continue to ship it and have no problem with getting fresh supplies of it.
FL real estate is improving so that may be why stock is rising.
Interesting only buying, .01 but up 900% from low. The dollar volume is still very small, but lately all the action has been on Ask.
All I know is some info got today from someone about Cobroxin not shipping on Amazon, but that company said there likley would be in a few months, will check out.
any news or update on XCHO ?? or is everybody in the dark just as me
...
First time over 50 day moving avg since May
The dollar volume is tiny but the stock has tripled. Tripling does not mean a lot at these levels, but better than going down.
100% gain for few bucks trade. the spread was .003 to .006 someone hit it to see 100% gain. meanlingless of course.
Up over 50% in last week, but from .0025. We will see if the move has legs.
Fidelity has caught up, shows .0125 trades and now 401,000 Bid at .009.
It may have just been temp blip.
Something may be up with XCHO, .0125
The worst bid/ask have seen was this morning, but the Bid was over 500,000 at .009 with .0099 small ask.
Just saw it at Fidelity with .01 trade and .0125 Bid and .0175 Ask, much better than it has been. See no news yet, and IB says it has traded 25,000 now at .0125 but Fidelity does not show that.
Have not been able to find news yet. XCHO has bascially produced no concrete news in a year. Maybe the drought is over.
WSJ Article Visa law, effects XCHO
this is what XCHO is doing now after the NPHC blowup. If it passes will help them do the deal they are attempting, which is selling overseas folks FL real Estate for Visas, as this increases the incentive for foriegn buyers.
By NICK TIMIRAOS
The reeling housing market has come to this: To shore it up, two Senators are preparing to introduce a bipartisan bill Thursday that would give residence visas to foreigners who spend at least $500,000 to buy houses in the U.S.
The provision is part of a larger package of immigration measures, co-authored by Sens. Charles Schumer (D., N.Y.) and Mike Lee (R., Utah), designed to spur more foreign investment in the U.S.
Getty Images
Supporters of the bill, co-authored by Sen. Charles Schumer, say it would help make up for American buyers who are holding back.
.
Foreigners have accounted for a growing share of home purchases in South Florida, Southern California, Arizona and other hard-hit markets. Chinese and Canadian buyers, among others, are taking advantage not only of big declines in U.S. home prices and reduced competition from Americans but also of favorable foreign exchange rates.
WSJ's Nick Timiraos details a proposed plan in which foreigners who spend $500,000 in cash on U.S. real estate would be given visas. Photo by Scott Olson/Getty Images</div>
.
To fuel this demand, the proposed measure would offer visas to any foreigner making a cash investment of at least $500,000 on residential real-estate—a single-family house, condo or townhouse. Applicants can spend the entire amount on one house or spend as little as $250,000 on a residence and invest the rest in other residential real estate, which can be rented out.
Journal Community
..
The measure would complement existing visa programs that allow foreigners to enter the U.S. if they invest in new businesses that create jobs. Backers believe the initiative would help soak up an excess supply of inventory when many would-be American home buyers are holding back because they're concerned about their jobs or because they would have to take a big loss to sell their current house.
"This is a way to create more demand without costing the federal government a nickel," Sen. Schumer said in an interview.
International buyers accounted for around $82 billion in U.S. residential real-estate sales for the year ending in March, up from $66 billion during the previous year period, according to data from the National Association of Realtors. Foreign buyers accounted for at least 5.5% of all home sales in Miami and 4.3% of Phoenix home sales during the month of July, according to MDA DataQuick.
Foreigners immigrating to the U.S. with the new visa wouldn't be able to work here unless they obtained a regular work visa through the normal process. They'd be allowed to bring a spouse and any children under the age of 18 but they wouldn't be able to stay in the country legally on the new visa once they sold their properties.
The provision would create visas that are separate from current programs so as to not displace anyone waiting for other visas. There would be no cap on the home-buyer visa program.
Over the past year, Canadians accounted for one quarter of foreign home buyers, and buyers from China, Mexico, Great Britain, and India accounted for another quarter, according to the National Association of Realtors. For buyers from some countries, restrictive immigration rules are "a deterrent to purchase here, for sure," says Sally Daley, a real-estate agent in Vero Beach, Fla. She estimates that around one-third of her sales this year have gone to foreigners, an all-time high.
"Without them, we would be stagnant," says Ms. Daley. "They're hiring contractors, buying furniture, and they're also helping the market correct by getting inventory whittled down."
In March, Harry Morrison, a Canadian from Lakefield, Ontario, bought a four-bedroom vacation home in a gated community in Vero Beach. "House prices were going down, and the exchange rate was quite favorable," said Mr. Morrison, who first bought a home there from Ms. Daley four years ago.
While a special visa would allow Canadian buyers like Mr. Morrison to spend more time in the U.S., he said he isn't sure "what other benefit a visa would give me."
The idea has some high-profile supporters, including Warren Buffett, who this summer floated the idea of encouraging more "rich immigrants" to buy homes. "If you wanted to change your immigration policy so that you let 500,000 families in but they have to have a significant net worth and everything, you'd solve things very quickly," Mr. Buffett said in an August interview with PBS's Charlie Rose.
The measure could also help turn around buyer psychology, said mortgage-bond pioneer Lewis Ranieri. He said the program represented "triage" for a housing market that needs more fixes, even modest ones.
But other industry executives greeted the proposal with skepticism. Foreign buyers "don't need an incentive" to buy homes, said Richard Smith, chief executive of Realogy Corp., which owns the Coldwell Banker and Century 21 real-estate brands. "We have a lot of Americans who are willing to buy. We just have to fix the economy."
The measure may have a more targeted effect in exclusive markets like San Marino, Calif., that have become popular with foreigners. Easier immigration rules could be "tremendous" because of the difficulty many Chinese buyers have in obtaining visas, says Maggie Navarro, a local real-estate agent.
Ms. Navarro recently sold a home for $1.67 million, around 8% above the asking price, to a Chinese national who works in the mining industry. She says nearly every listing she's put on the market in San Marino "has had at least one full price cash offer from a buyer from mainland China."
Corrections & Amplifications
Harry Morrison bought a four-bedroom vacation home in Vero Beach in March. He first bought a home there four years ago from Sally Daley, a local real-estate agent. An earlier version of this story incorrectly said Ms. Daley sold the four-bedroom home to Mr. Morrison in March.
Write to Nick Timiraos at nick.timiraos@wsj.com
Copyright 2011 Dow Jones & Company, Inc. All Rights Reserved
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit
www.djreprints.com
Back To MSN Money Homepage MSN Money Investing
They had a bunch of good news, even a profitible Q in 2010, then their partner NPHC turned on them, hurting both companies. XCHO has prodcued no significant good news since that August 2010 blowup.
That has killed the stock.
They are trying to restart the company now with a FL large condo project. The stock was this price prior to Cobroxin, so they may pull off another rise.
And to boot they are havimg trouble getting paid by customers.
What happened to this stock? Bounce coming soon? This pps is crazy.
no news 100%
The bid stayed at .018 after trading up 100% for the day. This thing needs some real news of progress. If it goes up another 100% tommorow then maybe there is some news in the works.
Got this from the latest 10-Q:
Accounts receivable are reported at net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. At March 31, 2011 and December 31, 2010, the allowance for doubtful accounts was $505,587 and $315,687, respectively.
Plus the Accounts receivable of $337,303, added up equals $1,158,577, but I'm not sure if the Dec/March "doubtful accounts" should be totaled that way, i.e. they may be cumulative, not write-offs, in which case you'd just add the $337k + $505K, still significant.
In any case, if even a fraction of that money due would have been paid, we'd have had positive revs in Q1:
Cash Flows from Operating Activities:
March 2011 Dec 2010
Net income (loss) $ (181,266 ) $ 109,485
CVS has been my pharmacy for many years, the local one has a fantastic staff, but I am NOT a happy camper to hear they're such laggards in paying suppliers.....
It is big. They need to collect on it. Gotta be throwing off their finances. But when the get it, will give them a lot of elbow room.
Yahoo says $337k Recievables. Likely moved to non-performing receivables already. This happens, bigco uses littleco as a bank by paying late, which hurts littleco more than it helps bigco.
Did you check the last 10-K to see what the accounts receivable number was? That's a huge amount of unpaid debt, wonder what it would do for the bottom line, earnings wise? It's just about equal to the initial amount of Cobroxin XCHO purchased from NPHC, isn't it?
Item 8.01 Other Events.
On July 8, 2011 XenaCare Holdings, Inc. (the “Company”) filed suit against CVS Caremark Corporation and CVS Pharmacy, Inc. in U.S. District Court, Middle District of Florida, West Palm Beach Division. The suit seeks payment of $1,254,943.34 owed to the Company for sales of products sold and delivered by the Company to the defendants from October 2008 through February 2011.
I have heard that both CVS and Riteaid can be very poor at paying. This looks an extreme case of that.
That is a lot of recievables, be good if they can get a settlement on it soon
STS, Yes. When said its the most undervalued stock have ever seen (UVE) meant it. About the only negative is that they make most of their money by being a hedgefund (investing all that cash they have). They make more from that than insurance, but then again that is a major part of being an insurance company, investing cash.
Only a couple of others have noticed this. It has been called best value stock out there by analysts about 3 months ago.
They strange thing is that they do not buy their own stock and go private and capture the cashflow at a discount.
On XCHO on a crash day being even with no trades is just fine with me.
Didn't even look at the cash....that's nuts! How can a company be trading for less than cash on hand?!? Something smells fishy in Denmark.....and the payout ratio is a paltry 28%, so they are easily covering the div payments.....wonder if there's some hidden problem, or if hedgies are responsible for that insane valuation?
BTW, have you checked up on the XCHO chart today? Still only 11k shares traded, and that was an early morning block, nothing at all since then. Bizarro world for both stocks.
STS, they have reinsurance, so getting wiped out should not be a possibility.
Their cash position is better than any have seen. Have you seen another company with 4PE, and more cash that mkt cap? If so let me know.
Will check that one too, thanks.
It's a "grey market" stock here in the USA, right now only traded on the Oslo exchange, but you can call your broker to buy it (no electronic trading here until it's on the NASDAQ).
Here's a link for the US market:
http://www.marketwatch.com/investing/stock/NATDF/charts?countryCode=US&submitted=true&intflavor=advanced&origurl=%2Ftools%2Fquotes%2Fintchart.asp&time=18&freq=7&comp=Enter%20Symbol%28s%29%3A&compidx=aaaaa~0&compind=aaaaa~0&uf=7168&ma=1&maval=50&lf=1&lf2=2097152&lf3=2&type=2&size=1&optstyle=1013
This one is for the Oslo exchange, hours ahead of us, so you can see what it closed for on the day in advance before you put in a bid:
http://translate.google.com/translate?u=http%3A%2F%2Fhopey.netfonds.no%2Fppaper.php%3Fpaper%3DNADL.OTC&tl=en
Good board for it (couldn't find one here on IHUB, maybe they'll open one after NATDF gets listed in the US):
http://www.investorvillage.com/smbd.asp?mb=16645
STS, can not find any financials
on NATDF Looks like a pink listing of foriegn stock. Do you have link to financials on it?
Not touching another small cap Chinese stock again, ever...was lucky to get in and out of SUTR (a steel maker) with a decent profit before it imploded....
As far as what's been driving my portfolio up, it's mostly John Fredriksen stocks, the Norwegian drilling/shipping magnate. I own SFL, SDRL, and GMLP (a recent spinoff/IPO from GLNG), NATDF (a recent spinoff/IPO from SDRL) and GLNG. I'm up a total of 49% in that group right now, and they account for a full 20% of my IRA's current gains over cash rolled over, even though NATDF and GMLP haven't really budged since they IPO'd (yet!).
You definitely want to pick up as much NATDF as you can afford, but don't chase it like I did, just put in a bid and wait for it to come to you - but beware, depending on your broker you may have to pay a foreign exchange trading fee of anywhere from $15 (TDA) to over $50 (Schwab, IIRC).
I got into NATDF in 3 spread out block buys a few months ago, unfortunately a tad early, can't believe it actually (briefly) dropped below the IPO price of $1.70...my basis is ~ $1.75, own as much as I intend on buying....waiting for it to get listed on the NASDAQ later this year when it'll take off like a rocket ship.....will also be getting the first div around Sept when they release their first ever quarterly report (the same applies to GMLP, report and div wise).
As far as XCHO, back to no volume today, which makes yesterday's action appear even weirder....still no news either....I don't follow NPHC - any news over there?
Good to hear you have done so well lately STS. The mkt has been on a tear.
One you might look at is SDTH, a chinese stock that cooked their books but is an leader in their industry. If they doubled the value thru cooking, then its a bargain, already tripled off reopen, which was 95% off prior prices.
Lately for me its been miner stocks and the metals helping the accts.
I noticed the same thing, also couldn't find any news anywhere. Weird. NPHC had a rather busy day too, it would appear....the price % increase (33%) is of course rather meaningless (shut up, BE, we don't care what you have to say), but the volume is interesting to say the least.
As far as a "real" stock goes, my HOTT shares soared 15% today, unbelievable....they actually booked a profit this quarter! I was going to dump them as soon as I got back to green, but now that I'm there it makes more sense to hold onto them thru the back to school season, at a minimum. They even pay a divvy, believe it or not...only 7 cents/qtr, but hey, it's better than nothing
The last two weeks have been very, very good for my IRA, one more day like today and I'll back at my peak value or higher, this time with a different mix of stocks/funds, despite my XCHO/ARNA (paper) losses, which makes it even more impressive - ARNA could still be a huge winner over time, especially if the CRO report we're waiting on refutes the nutty rat tumor statistical BS the FDA pulled on them at their Lorcaserin AdCom - it's fully expected to do so, despite what some nutjob on TheStreet.com claims.
But picking up GLNG earlier this year might have been the best stock pick I've ever made, it's up more than 107% in less than 5 months, whew, what a ride!
Unusual activity, no reason apparent
The bid is up 30% and volume over 350,000 today. Have not been able to find any news on it.
Followers
|
49
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
5204
|
Created
|
07/30/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |